婴儿血管瘤是一种良性血管肿瘤，在儿童时期最常见，其自然演变是病变在儿科时期消失，有效且安全的治疗方法可以限制其生长并有利于其在年轻时消失。由于错误诊断、缺乏对病情的了解、转诊较晚或担心治疗药物的影响，婴儿血管瘤仍然是引起人们关注并发症的一个原因。此外，它的存在被正常化，没有考虑到它可能导致不确定性、焦虑、内疚感，从而对生活质量（主要是儿童的父母或照顾者）产生重大影响。尽管有足够的治疗方法、医学的不断发展和新证据的出现，但我国仍需要制定临床实践指南，因为婴儿血管瘤晚期缓解并发症的发病率很高。在整个指南中，您将找到有关婴儿血管瘤患者的诊断、治疗和随访的建议，其中考虑到可以进行的临床旁测试、局部或全身治疗方案以及辅助治疗。婴儿血管瘤治疗指南首次纳入患者随访的客观工具，并帮助首次联系的医生及时转诊。版权所有：© 2024 Permanyer。

Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral.Copyright: © 2024 Permanyer.